Aids in the detection of nonclassical congenital adrenal hyperplasia in individuals presenting with hyperandrogenism.
Quantitative High Performance Liquid Chromatography-Tandem Mass Spectrometry
New York DOH Approval Status
Collect between 6-10 a.m.
Serum separator tube or green (sodium or lithium heparin). Also acceptable: Pink (K2EDTA).
Separate serum or plasma from cells ASAP or within 2 hours of collection. Transfer 1.2 mL serum or plasma to an ARUP Standard Transport Tube. (Min: 0.7 mL)
Ambient: 24 hours; Refrigerated: 1 week; Frozen: 6 months
|2001638||Androstenedione||Effective August 19, 2013
|0092332||17-Hydroxyprogesterone Quantitative by HPLC-MS/MS, Serum or Plasma||Effective August 19, 2013
|0081058||Testosterone, Females or Children||Effective August 19, 2013
|2001640||Dehydroepiandrosterone, Serum or Plasma||Effective August 19, 2013
Total testosterone values may not reflect optimal concentrations in all individuals. Free or bioavailable testosterone measurements may provide supportive information.
This test was developed and its performance characteristics determined by ARUP Laboratories. It has not been cleared or approved by the US Food and Drug Administration. This test was performed in a CLIA certified laboratory and is intended for clinical purposes.
Laboratory Developed Test (LDT)
82157; 83498; 84403; 82626
|Component Test Code*||Component Chart Name||LOINC|
|2001639||Androstenedione by TMS||1854-9|
|2001641||Dehydroepiandrosterone by TMS||2193-1|
- 17-Hydroxyprogesterone (Virilization Panel 2)
- Androstenedione (Virilization Panel 2)
- Dehydroepiandrosterone (Virilization Panel 2)
- Testosterone (Virilization Panel 2)